AFG
AXDX

Albion Financial Group’s Accelerate Diagnostics AXDX Stock Holding History

Albion Financial Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-212
Closed -$149 – 588
2025
Q1 		$149 Hold
212
– – ﹤0.01% 586
2024
Q4 		$255 Hold
212
– – ﹤0.01% 653
2024
Q3 		$363 Hold
212
– – ﹤0.01% 480
2024
Q2 		$249 Hold
212
– – ﹤0.01% 490
2024
Q1 		$210 Hold
212
– – ﹤0.01% 482
2023
Q4 		$832 Sell
212
-1,500
-88% -$7.93K ﹤0.01% 436
2023
Q3 		$9.84K Buy
+1,712
New +$11.5K ﹤0.01% 297
2023
Q2 		– Sell
-213
Closed -$1.49K – 474
2023
Q1 		$1.49K Hold
213
– – ﹤0.01% 382
2022
Q4 		$1.5K Hold
213
– – ﹤0.01% 405
2022
Q3 		$3K Hold
213
– – ﹤0.01% 369
2022
Q2 		$2K Hold
213
– – ﹤0.01% 409
2022
Q1 		$3K Hold
213
– – ﹤0.01% 438
2021
Q4 		$11K Hold
213
– – ﹤0.01% 398
2021
Q3 		$12K Hold
213
– – ﹤0.01% 354
2021
Q2 		$17K Buy
+213
New +$16.9K ﹤0.01% 341
2020
Q4 		$16K Buy
+213
New +$19.1K ﹤0.01% 321
2019
Q4 		– Sell
-1,086
Closed -$202K – 219
2019
Q3 		$202K Hold
1,086
– – 0.03% 191
2019
Q2 		$248K Hold
1,086
– – 0.03% 181
2019
Q1 		$228K Sell
1,086
-755
-41% -$142K 0.03% 177
2018
Q4 		$212K Sell
1,841
-1,025
-36% -$152K 0.03% 178
2018
Q3 		$658K Sell
2,866
-645
-18% -$143K 0.09% 117
2018
Q2 		$783K Sell
3,511
-1,867
-35% -$418K 0.11% 106
2018
Q1 		$1.23M Sell
5,378
-320
-6% -$84K 0.19% 80
2017
Q4 		$1.49M Sell
5,698
-130
-2% -$30.5K 0.23% 74
2017
Q3 		$1.31M Hold
5,828
– – 0.2% 77
2017
Q2 		$1.59M Hold
5,828
– – 0.26% 63
2017
Q1 		$1.41M Sell
5,828
-1,670
-22% -$382K 0.21% 71
2016
Q4 		$1.56M Buy
7,498
+450
+6% +$107K 0.26% 65
2016
Q3 		$1.92M Sell
7,048
-6
-0.1% -$1.33K 0.33% 58
2016
Q2 		$1.01M Sell
7,054
-5
-0.1% -$671 0.18% 70
2016
Q1 		$1.01M Buy
7,059
+750
+12% +$106K 0.17% 73
2015
Q4 		$1.36M Buy
6,309
+840
+15% +$153K 0.23% 54
2015
Q3 		$885K Buy
5,469
+800
+17% +$173K 0.16% 80
2015
Q2 		$1.21M Sell
4,669
-300
-6% -$71.6K 0.2% 65
2015
Q1 		$1.12M Sell
4,969
-702
-12% -$147K 0.19% 66
2014
Q4 		$1.09M Sell
5,671
-1
-0% -$214 0.19% 67
2014
Q3 		$1.22M Buy
5,672
+1,255
+28% +$244K 0.22% 65
2014
Q2 		$1.15M Buy
4,417
+105
+2% +$22.9K 0.2% 71
2014
Q1 		$940K Sell
4,312
-100
-2% -$14.8K 0.17% 77
2013
Q4 		$538K Sell
4,412
-670
-13% -$89.6K 0.1% 101
2013
Q3 		$681K Hold
5,082
– – 0.15% 83
2013
Q2 		$413K Buy
+5,082
New +$377K 0.09% 97

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Albion Financial Group's AXDX Position: Q2 2025 in Review

Albion Financial Group sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 212 shares — an estimated $149 sold.

Albion Financial Group first reported a position in AXDX in Q2 2013 and held it in 42 quarters. The position peaked at $1.92M in Q3 2016. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • Albion Financial Group reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Albion Financial Group sold 212 Accelerate Diagnostics shares in Q2 2025, an estimated $149.
  • Albion Financial Group first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 42 quarters.
  • Albion Financial Group's Accelerate Diagnostics position peaked at $1.92M in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Albion Financial Group's 13F filing for Q2 2025, filed 17 Jul 2025.